# Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

> **NCT06157567** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Candela Corporation** · enrollment: 500 (estimated)

## Conditions studied

- Skin Laxity
- Wrinkle
- Skin Condition

## Interventions

- **DEVICE:** Profound Matrix

## Key facts

- **NCT ID:** NCT06157567
- **Lead sponsor:** Candela Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-24
- **Primary completion:** 2027-05-24
- **Final completion:** 2028-05-24
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06157567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06157567, "Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06157567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*